NCT00210652 An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy Status COMPLETED Phase PHASE2
NCT00210522 An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy Status COMPLETED Phase PHASE2
NCT00207935 Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population Status COMPLETED Phase PHASE4
NCT00195052 Intrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy Patients Status TERMINATED Phase N/A
NCT00194870 Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy Status COMPLETED Phase NA
NCT00188500 Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy Status UNKNOWN Phase NA
NCT00181090 Use of the Atkins Diet for Children With Intractable Epilepsy: A Comparison of Daily Carbohydrate Limits Status COMPLETED Phase PHASE1
NCT00179426 Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy Status COMPLETED Phase N/A
NCT00175916 Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy Status COMPLETED Phase PHASE3
NCT00175903 Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy Status COMPLETED Phase PHASE3
NCT00175864 Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. Status WITHDRAWN Phase PHASE3
NCT00175851 Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy Status WITHDRAWN Phase PHASE3
NCT00175825 A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures. Status COMPLETED Phase PHASE2
NCT00165828 Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization Status TERMINATED Phase PHASE4
NCT00158067 Study of an External Responsive Neurostimulator System on Epileptiform Activity Status COMPLETED Phase PHASE2